Global GLP-1 Agonist Supply, Demand and Key Producers, 2023-2029

Global GLP-1 Agonist Supply, Demand and Key Producers, 2023-2029

The global GLP-1 Agonist market size is expected to reach $ 59500 million by 2029, rising at a market growth of 15.9% CAGR during the forecast period (2023-2029).

GLP-1 is a polypeptide hormone secreted by the intestine after being stimulated by food. It can stimulate the pancreatic beta cells to secrete insulin and participate in the regulation of blood sugar balance in the human body. However, natural GLP-1 is easily degraded by dipeptidyl peptidase in vivo and loses its activity. In order to make GLP-1 better for clinical application, drug developers have modified its structure and developed a series of GLP-1 receptor agonists. GLP-1 receptor agonists can exert the same biological effects as natural GLP-1, and can also avoid being degraded and inactivated, thereby prolonging the action time.

This report studies the global GLP-1 Agonist production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for GLP-1 Agonist, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of GLP-1 Agonist that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global GLP-1 Agonist total production and demand, 2018-2029, (K Units)

Global GLP-1 Agonist total production value, 2018-2029, (USD Million)

Global GLP-1 Agonist production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global GLP-1 Agonist consumption by region & country, CAGR, 2018-2029 & (K Units)

U.S. VS China: GLP-1 Agonist domestic production, consumption, key domestic manufacturers and share

Global GLP-1 Agonist production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)

Global GLP-1 Agonist production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global GLP-1 Agonist production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)

This reports profiles key players in the global GLP-1 Agonist market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novo Nordisk, AstraZeneca, Sanofi, GSK, Eli Lilly, Zealand Pharma A/S, hansoh and BENEMAE, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World GLP-1 Agonist market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global GLP-1 Agonist Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global GLP-1 Agonist Market, Segmentation by Type
Long-Acting Drug
Short-Acting Drug

Global GLP-1 Agonist Market, Segmentation by Application
Diabetes
Obesity
Nonalcoholic Fatty Liver Disease
Metabolic Disorder
Alzheimer's Disease
Other

Companies Profiled:
Novo Nordisk
AstraZeneca
Sanofi
GSK
Eli Lilly
Zealand Pharma A/S
hansoh
BENEMAE

Key Questions Answered

1. How big is the global GLP-1 Agonist market?

2. What is the demand of the global GLP-1 Agonist market?

3. What is the year over year growth of the global GLP-1 Agonist market?

4. What is the production and production value of the global GLP-1 Agonist market?

5. Who are the key producers in the global GLP-1 Agonist market?

6. What are the growth factors driving the market demand?